Spravato Treatment (ESKetamine) in NYC

Spravato ® Treatment in New York City

Spravato ® (esketamine) nasal spray is apprived by the FDA in conjunction with an oral antidepressant, for the treatment
of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-
resistant depression). Because of the risk of serious adverse outcomes resulting from sedation and dissociation caused
by Spravato administration, and the potential for abuse and misuse of the drug, it is only available through a restricted
distribution system, under a Risk Evaluation and Mitigation Strategy (REMS).